GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma.
Xie X, Cai X, Zhou F, Li Y, Liu Q, Cai L, Zhu W, Wei J, Jin C, Liu Z, Jiang C, Zhao H, Yang L, Zhao C, Huang X.
Xie X, et al. Among authors: li y.
Pharmacol Res. 2022 Sep;183:106389. doi: 10.1016/j.phrs.2022.106389. Epub 2022 Aug 5.
Pharmacol Res. 2022.
PMID: 35934193
Free article.